Last week’s hot topic on Lymphoma was about the Researchers who Developed Promising Cancer Drug to Treat Mantle Cell Lymphoma written by Carolina Henriques.
The article is centered around the researchers who have developed a promising cancer drug which can be used to treat mantle cell lymphoma. The drug has now been licensed to the U.S. pharmaceutical company Merck in a $730 million deal.
Thanks to the work of the researchers from the Center Therapeutics CRC (CTx), we are one step closer to treating mantle cell lymphoma.
Read more articles about lymphoma here: http://bit.ly/1LJAd9O
